Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FARDE L' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 173 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Halldin, C; Gulyas, B; Langer, O; Farde, L
      Brain radioligands - State of the art and new trends

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    2. Olsson, H; Farde, L
      Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy - A simulationstudy based on experimental data

      NEUROIMAGE
    3. Ito, H; Sudo, Y; Suhara, T; Okubo, Y; Halldin, C; Farde, L
      Error analysis for quantification of [C-11]FLB 457 binding to extrastriatal D-2 dopamine receptors in the human brain

      NEUROIMAGE
    4. Sandell, J; Halldin, C; Pike, VW; Chou, YH; Varnas, K; Hall, H; Marchais, S; Nowicki, B; Wikstrom, HV; Swahn, CG; Farde, L
      New halogenated [C-11]WAY analogues, [C-11]6FPWAY and [C-11]6BPWAY - Radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey

      NUCLEAR MEDICINE AND BIOLOGY
    5. Nobuhara, K; Farde, L; Halldin, C; Karlsson, P; Swahn, CG; Olsson, H; Bergstrom, KA; Larsson, SA; Schnell, PO; McPherson, DW; Savonen, A; Hiltunen, J; Sedvall, G
      SPET imaging of central muscarinic acetylcholine receptors with iodine-123labelled E-IQNP and Z-IQNP

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    6. Sudo, Y; Suhara, T; Inoue, M; Ito, H; Suzuki, K; Saijo, T; Halldin, C; Farde, L
      Reproducibility of [C-11]FLB 457 binding in extrastriatal regions

      NUCLEAR MEDICINE COMMUNICATIONS
    7. Backman, L; Farde, L
      Dopamine and cognitive functioning: Brain imaging findings in Huntington'sdisease and normal aging

      SCANDINAVIAN JOURNAL OF PSYCHOLOGY
    8. Talvik, M; Nordstrom, AL; Nyberg, S; Olsson, H; Halldin, C; Farde, L
      No support for regional selectivity in clozapine-treated patients: A PET study with [C-11]raclopride and [C-11]FLB 457

      AMERICAN JOURNAL OF PSYCHIATRY
    9. Kaasinen, V; Nagren, K; Hietala, J; Farde, L; Rinne, JO
      Sex differences in extrastriatal dopamine D-2-like receptors in the human brain

      AMERICAN JOURNAL OF PSYCHIATRY
    10. Farde, L; Ginovart, N; Halldin, C; Chou, YH; Olsson, H; Swahn, CG
      A PET study of [C-11]beta-CIT-FE binding to the dopamine transporter in the monkey and human brain

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    11. Langer, O; Halldin, C; Chou, YH; Sandell, J; Swahn, CG; Nagren, K; Perrone, R; Berardi, F; Leopoldo, M; Farde, L
      Carbon-11 PB-12: An attempt to visualize the dopamine D-4 receptor in the primate brain with positron emission tomography

      NUCLEAR MEDICINE AND BIOLOGY
    12. Pike, VW; Halldin, C; Wikstrom, H; Marchais, S; McCarron, JA; Sandell, J; Nowicki, B; Swahn, CG; Osman, S; Hume, SP; Constantinou, M; Andree, B; Farde, L
      Radioligands for the study of brain 5-HT1A receptors in vivo - Developmentof some new analogues of WAY

      NUCLEAR MEDICINE AND BIOLOGY
    13. Andree, B; Halldin, C; Thorberg, SO; Sandell, J; Farde, L
      Use of PET and the radioligand [Carbonyl-C-11]WAY-100635 in psychotropic drug development

      NUCLEAR MEDICINE AND BIOLOGY
    14. Farde, L; Andree, B; Ginovart, N; Halldin, C; Thorberg, SO
      PET-determination of robalzotan (NAD-299) induced 5-HT1A receptor occupancy in the monkey brain

      NEUROPSYCHOPHARMACOLOGY
    15. Hall, H; Farde, L; Halldin, C; Lundkvist, C; Sedvall, G
      Autoradiographic localization of 5-HT2A receptors in the human brain using(LH)-H-3]M100907 and [C-11]M100907

      SYNAPSE
    16. Chou, YH; Halldin, C; Farde, L
      Effect of amphetamine on extrastriatal D2 dopamine receptor binding in theprimate brain: A PET study

      SYNAPSE
    17. Langer, O; Gulyas, B; Sandell, J; Laszlovszky, I; Kiss, B; Domany, G; Acs, T; Farde, L; Halldin, C
      Radiochemical labelling of the dopamine D-3 receptor ligand RGH-1756

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    18. Sandell, J; Halldin, C; Helfenbein, J; Chou, YH; Vercouillie, J; Emond, P; Swahn, CG; Guilloteau, D; Farde, L
      Synthesis of [C-11]2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-methyl, -ethyland isopropyl phenyl)nortropane as potential radiotracers for examination of the serotonin transporter with positron emission tomography

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    19. Kaasinen, V; Vilkman, H; Hietala, J; Nagren, K; Helenius, H; Olsson, H; Farde, L; Rinne, JO
      Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain

      NEUROBIOLOGY OF AGING
    20. Kaasinen, V; Nagren, K; Hietala, J; Oikonen, V; Vilkman, H; Farde, L; Halldin, C; Rinne, JO
      Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease

      NEUROLOGY
    21. Backman, L; Ginovart, N; Dixon, RA; Wahlin, TBR; Wahlin, A; Halldin, C; Farde, L
      Age-related cognitive deficits mediated by changes in the striatal dopamine system

      AMERICAN JOURNAL OF PSYCHIATRY
    22. Nobuhara, K; Halldin, C; Hall, H; Karlsson, P; Farde, L; Hiltunen, J; McPherson, DW; Savonen, A; Bergstrom, KA; Pauli, S; Swahn, CG; Larsson, SA; Schnell, PO; Sedvall, G
      Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease

      PSYCHOPHARMACOLOGY
    23. Talvik-Lotfi, M; Nyberg, S; Nordstrom, AL; Ito, H; Halldin, C; Brunner, F; Farde, L
      High 5HT(2A) receptor occupancy in M100907-treated schizophrenic patients

      PSYCHOPHARMACOLOGY
    24. Nyberg, S; Farde, L
      Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies

      PSYCHOPHARMACOLOGY
    25. Jonsson, EG; Nothen, MM; Grunhage, F; Farde, L; Nakashima, Y; Propping, P; Sedvall, GC
      Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers

      MOLECULAR PSYCHIATRY
    26. Ito, H; Okubo, Y; Halldin, C; Farde, L
      Mapping of central D-2 dopamine receptors in man using [C-11]raclopride: PET with anatomic standardization technique

      NEUROIMAGE
    27. Hall, H; Halldin, C; Guilloteau, D; Chalon, S; Emond, P; Besnard, JC; Farde, L; Sedvall, G
      Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I

      NEUROIMAGE
    28. Okubo, Y; Olsson, H; Ito, H; Lofti, M; Suhara, T; Halldin, C; Farde, L
      PET mapping of extrastriatal D2-like dopamine receptors in the human brainusing an anatomic standardization technique and [C-11]FLB 457

      NEUROIMAGE
    29. Gulyas, B; Halldin, C; Karlsson, P; Chou, YH; Swahn, CG; Bonock, P; Paroczai, M; Farde, L
      Brain uptake and plasma metabolism of [C-11]vinpocetine: A preliminary PETstudy in a cynomolgus monkey

      JOURNAL OF NEUROIMAGING
    30. Helfenbein, J; Sandell, J; Halldin, C; Chalon, S; Emond, P; Okubo, Y; Chou, YH; Frangin, Y; Douziech, L; Gareau, L; Swahn, CG; Besnard, JC; Farde, L; Guilloteau, D
      PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter

      NUCLEAR MEDICINE AND BIOLOGY
    31. Lundkvist, C; Loc'h, C; Halldin, C; Bottlaender, M; Ottaviani, M; Coulon, C; Fuseau, C; Mathis, C; Farde, L; Maziere, B
      Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter

      NUCLEAR MEDICINE AND BIOLOGY
    32. Langer, O; Halldin, C; Dolle, F; Swahn, CG; Olsson, H; Karlsson, P; Hall, H; Sandell, J; Lundkvist, C; Vaufrey, F; Loc'h, C; Crouzel, C; Maziere, B; Farde, L
      Carbon-11 epidepride: A suitable radioligand for PET investigation of striatal and extrastriatal dopamine D-2 receptors

      NUCLEAR MEDICINE AND BIOLOGY
    33. Lundkvist, C; Halldin, C; Swahn, CG; Ginovart, N; Farde, L
      Different brain radioactivity curves in a PET study with [C-11]beta-CIT labelled in two different positions

      NUCLEAR MEDICINE AND BIOLOGY
    34. Sandell, J; Halldin, C; Hall, H; Thorberg, SO; Werner, T; Sohn, D; Sedvall, G; Farde, L
      Radiosynthesis and autoradiographic evaluation of [C-11]NAD-299, a radioligand for visualization of the 5-HT1A receptor

      NUCLEAR MEDICINE AND BIOLOGY
    35. Ginovart, N; Farde, L; Halldin, C; Swahn, CG
      Changes in striatal D-2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates

      SYNAPSE
    36. Bergstrom, KA; Halldin, C; Savonen, A; Okubo, Y; Hiltunen, J; Nobuhara, K; Swahn, CG; Karlsson, P; McPherson, D; Knapp, FF; Larsson, S; Schnell, PO; Farde, L
      Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M-1 and M-2 muscarinic acetylcholine receptors in Alzheimer's disease

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    37. Olsson, H; Halldin, C; Swahn, CG; Farde, L
      Quantification of [C-11]FLB 457 binding to extrastriatal dopamine receptors in the human brain

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    38. Ito, H; Halldin, C; Farde, L
      Localization of 5-HT1A receptors in the living human brain using [carbonyl-C-11]WAY-100635: PET with anatomic standardization technique

      JOURNAL OF NUCLEAR MEDICINE
    39. Nyberg, S; Eriksson, B; Oxenstierna, G; Halldin, C; Farde, L
      Suggested minimal effective dose of risperidone based on PET-measured D-2 and 5-HT2A receptor occupancy in schizophrenic patients

      AMERICAN JOURNAL OF PSYCHIATRY
    40. Chou, YH; Karlsson, P; Halldin, C; Olsson, H; Farde, L
      A PET study of D-1-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain

      PSYCHOPHARMACOLOGY
    41. Andree, B; Thorberg, SO; Halldin, C; Farde, L
      Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography

      PSYCHOPHARMACOLOGY
    42. HALL H; HALLDIN C; FARDE L; SEDVALL G
      WHOLE HEMISPHERE AUTORADIOGRAPHY OF THE POSTMORTEM HUMAN BRAIN

      Nuclear medicine and biology
    43. FOGED C; HALLDIN C; SWAHN CG; GINOVART N; KARLSSON P; LUNDKVIST C; FARDE L
      [C-11] NNC-22-0215, A METABOLICALLY STABLE DOPAMINE D-1 RADIOLIGAND FOR PET

      Nuclear medicine and biology
    44. EMOND P; FARDE L; CHALON S; BELZUNG C; MAUCLAIRE V; CHIRON JP; HALLDIN C; BESNARD JC; GUILLOTEAU D
      TOXICITY, MUTAGENICITY, AND BEHAVIORAL-EFFECTS OF BETA-CIT, A LIGAND FOR DOPAMINE TRANSPORTER EXPLORATION BY SPECT

      Nuclear medicine and biology
    45. BERGSTROM KA; HALLDIN C; HILTUNEN J; SWAHN CG; ITO H; GINOVART N; HALL H; MCPHERSON DW; KNAPP FFR; LARSSON S; SCHNELL PO; FARDE L
      EVALUATION AND METABOLITE STUDIES OF I-125-LABELED AND I-123-LABELED E-(R,R)-IQNP - POTENTIAL RADIOLIGANDS FOR VISUALIZATION OF M-1 MUSCARINIC ACETYLCHOLINE-RECEPTORS IN BRAIN

      Nuclear medicine and biology
    46. OSMAN S; LUNDKVIST C; PIKE VW; HALLDIN C; MCCARRON JA; SWAHN CG; FARDE L; GINOVART N; LUTHRA SK; GUNN RN; BENCH CJ; SARGENT PA; GRASBY PM
      CHARACTERIZATION OF THE APPEARANCE OF RADIOACTIVE METABOLITES IN MONKEY AND HUMAN PLASMA FROM THE 5-HT1A RECEPTOR RADIOLIGAND, [CARBONYL-C-11]WAY-100635 - EXPLANATION OF HIGH SIGNAL CONTRAST IN PET AND AN AID TO BIOMATHEMATICAL MODELING

      Nuclear medicine and biology
    47. FARDE L
      D2-DENSITY, PERSONALITY-TRAITS, AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

      Schizophrenia research
    48. FARDE L
      D-2 DENSITY, PERSONALITY-TRAITS, AND COGNITIVE FUNCTIONS

      Nordic journal of psychiatry
    49. FARDE L
      NEUROIMAGING IN PSYCHIATRY

      Nordic journal of psychiatry
    50. KUIKKA JT; BAULIEU JL; HILTUNEN J; HALLDIN C; BERGSTROM KA; FARDE L; EMOND P; CHALON S; YU MX; NIKULA T; LAITINEN T; KARHU J; TUPALA E; HALLIKAINEN T; KOLEHMAINEN V; MAUCLAIRE L; MAZIERE B; TIIHONEN J; GUILLOTEAU D
      PHARMACOKINETICS AND DOSIMETRY OF I-123 LABELED PE2I IN HUMANS, A RADIOLIGAND FOR DOPAMINE TRANSPORTER IMAGING

      European journal of nuclear medicine
    51. PIKE VW; HALLDIN C; MCCARRON JA; LUNDKVIST C; HIRANI E; OLSSON H; HUME SP; KARLSSON P; OSMAN S; SWAHN CG; HALL H; WIKSTROM H; MENSONIDAS M; POOLE KG; FARDE L
      [CARBONYL-C-11]DESMETHYL-WAY-100635 (DWAY) IS A POTENT AND SELECTIVE RADIOLIGAND FOR CENTRAL 5-HT1A RECEPTORS IN-VITRO AND IN-VIVO

      European journal of nuclear medicine
    52. HILTUNEN J; AKERMAN KK; KUIKKA JT; BERGSTROM KA; HALLDIN C; NIKULA T; RASANEN P; TIIHONEN J; VAUHKONEN M; KARHU J; KUPILA J; LANSIMIES E; FARDE L
      I-123 LABELED NOR-BETA-CIT AS A POTENTIAL TRACER FOR SEROTONIN TRANSPORTER IMAGING IN THE HUMAN BRAIN WITH SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    53. ITO H; HIETALA J; BLOMQVIST G; HALLDIN C; FARDE L
      COMPARISON OF THE TRANSIENT EQUILIBRIUM AND CONTINUOUS-INFUSION METHOD FOR QUANTITATIVE PET ANALYSIS OF [C-11] RACLOPRIDE BINDING

      Journal of cerebral blood flow and metabolism
    54. NORDSTROM AL; FARDE L
      PLASMA PROLACTIN AND CENTRAL D-2 RECEPTOR OCCUPANCY IN ANTIPSYCHOTIC DRUG-TREATED PATIENTS

      Journal of clinical psychopharmacology
    55. ANDREE B; NYBERG S; ITO H; GINOVART N; BRUNNER F; JAQUET F; HALLDIN C; FARDE L
      POSITRON EMISSION TOMOGRAPHIC ANALYSIS OF DOSE-DEPENDENT MDL-100,907 BINDING TO 5-HYDROXYTRYPTAMINE-2A RECEPTORS IN THE HUMAN BRAIN

      Journal of clinical psychopharmacology
    56. NYBERG S; NILSSON U; OKUBO Y; HALLDIN C; FARDE L
      IMPLICATIONS OF BRAIN IMAGING FOR THE MANAGEMENT OF SCHIZOPHRENIA

      International clinical psychopharmacology
    57. SUHARA T; SUDO Y; SUZUKI K; OKAUCHI T; FARDE L; HALLDIN C; TANADA S; SASAKI Y
      QUANTITATIVE-ANALYSIS OF EXTRASTRIATAL DOPAMINE D2 RECEPTORS IN THE HUMAN BRAIN BY 3D PET

      The Journal of nuclear medicine
    58. HALLDIN C; GUILLOTEAU D; OKUBO Y; LUNDKVIST C; OLSSON H; KARLSSON P; CHALON S; EMOND P; SWAHN CG; FARDE L
      PET-CHARACTERIZATION OF [C-11] PE2I BINDING TO DOPAMINE TRANSPORTER IN THE MONKEY BRAIN

      The Journal of nuclear medicine
    59. SANDELL J; HELFENBEIN J; HALLDIN C; OKUBO Y; CHALON S; FRANGIN Y; GALINIER E; SWAHN CG; GUILLOTEAU D; FARDE L
      PRECURSOR SYNTHESIS, RADIOLABELING AND PET EXAMINATION IN MONKEY OF 3POTENT SEROTONIN TRANSPORTER RADIOLIGANDS

      The Journal of nuclear medicine
    60. ITO H; HALLDIN C; FARDE L
      LOCALIZATION OF CENTRAL 5-HT1A RECEPTORS IN MAN USING [CARBONYL-C-11]WAY-100635 - PET WITH ANATOMIC STANDARDIZATION TECHNIQUE

      The Journal of nuclear medicine
    61. SANDELL J; HALLDIN C; THORBERG SO; WERNER T; SOHN D; SEDVALL G; FARDE L
      RADIOSYNTHESIS AND HUMAN POSTMORTEM AUTORADIOGRAPHY OF [C-11] NAD-299, A NEW RADIOLIGAND FOR VISUALIZATION OF THE 5-HT1A RECEPTOR

      The Journal of nuclear medicine
    62. FARDE L; ITO H; SWAHN CG; PIKE VW; HALLDIN C
      QUANTITATIVE-ANALYSES OF CARBONYL-CARBON-11-WAY-100635 BINDING TO CENTRAL 5-HYDROXYTRYPTAMINE-1A RECEPTORS IN MAN

      The Journal of nuclear medicine
    63. ITO H; NYBERG S; HALLDIN C; LUNDKVIST C; FARDE L
      PET IMAGING OF CENTRAL 5-HT2A RECEPTORS WITH CARBON-11-MDL-100,907

      The Journal of nuclear medicine
    64. Halldin, C; Foged, C; Chou, YH; Karlsson, P; Swahn, CG; Sandell, J; Sedvall, G; Farde, L
      Carbon-11-NNC 112: A radioligand for PET examination of striatal and neocortical D-1-dopamine receptors

      JOURNAL OF NUCLEAR MEDICINE
    65. JONSSON EG; NOTHEN MM; NEIDT H; FARDE L; PROPPING P; SEDVALL GC
      POLYMORPHISMS IN THE DOPAMINE D2 RECEPTOR GENE AND THEIR RELATIONSHIPS TO STRIATAL DOPAMINE-RECEPTOR DENSITY IN-VIVO OF HEALTHY-VOLUNTEERS

      American journal of medical genetics
    66. NORDSTROM AL; NYBERG S; OLSSON H; FARDE L
      POSITRON-EMISSION-TOMOGRAPHY FINDING OF A HIGH STRIATAL D-2 RECEPTOR OCCUPANCY IN OLANZAPINE-TREATED PATIENTS

      Archives of general psychiatry
    67. LUNDKVIST C; HALLDIN C; GINOVART N; SWAHN CG; FARDE L
      [F-18] BETA-CIT-FP IS SUPERIOR TO [C-11] BETA-CIT-FP FOR QUANTITATIONOF THE DOPAMINE TRANSPORTER

      Nuclear medicine and biology
    68. GUNTHER I; HALL H; HALLDIN C; SWAHN CG; FARDE L; SEDVALL G
      [I-125] BETA-CIT-FE AND [I-125] BETA-CIT-FP ARE SUPERIOR TO [I-125] BETA-CIT FOR DOPAMINE TRANSPORTER VISUALIZATION - AUTORADIOGRAPHIC EVALUATION IN THE HUMAN BRAIN

      Nuclear medicine and biology
    69. HALL H; HALLDIN C; JERNING E; OSTERLUND M; FARDE L; SEDVALL G
      AUTORADIOGRAPHIC COMPARISON OF [I-125] EPIDEPRIDE AND [I-125] NCQ-298BINDING TO HUMAN BRAIN EXTRASTRIATED DOPAMINE-RECEPTORS

      Nuclear medicine and biology
    70. FARDE L
      BRAIN IMAGING OF SCHIZOPHRENIA - THE DOPAMINE HYPOTHESIS

      Schizophrenia research
    71. KARLSSON P; FARDE L; HALLDIN C; SEDVALL G
      D-1-DOPAMINE RECEPTORS IN SCHIZOPHRENIA EXAMINED BY PET

      Schizophrenia research
    72. NYBERG S; FARDE L; HALLDIN C
      A PET STUDY OF 5-HT2 AND D-2 DOPAMINE-RECEPTOR OCCUPANCY INDUCED BY OLANZAPINE IN HEALTHY-SUBJECTS

      Neuropsychopharmacology
    73. GINOVART N; FARDE L; HALLDIN C; SWAHN CG
      EFFECT OF RESERPINE-INDUCED DEPLETION OF SYNAPTIC DOPAMINE ON [C-11] RACLOPRIDE BINDING TO D-2-DOPAMINE RECEPTORS IN THE MONKEY BRAIN

      Synapse
    74. BERGSTROM KA; HALLDIN C; HALL H; LUNDKVIST C; GINOVART N; SWAHN CG; FARDE L
      IN-VITRO AND IN VIVE CHARACTERIZATION OF NOR-BETA-CIT - A POTENTIAL RADIOLIGAND FOR VISUALIZATION OF THE SEROTONIN TRANSPORTER IN THE BRAIN

      European journal of nuclear medicine
    75. FOGED C; HALLDIN C; LOCH C; MAZIERE B; PAULI S; MAZIERE M; HANSEN HC; SUHARA T; SWAHN CG; KARLSSON P; FARDE L
      BR-76 AND C-11 LABELED NNC-13-8199, METABOLICALLY STABLE BENZODIAZEPINE RECEPTOR AGONISTS AS RADIOLIGANDS FOR POSITRON-EMISSION-TOMOGRAPHY (PET)

      European journal of nuclear medicine
    76. BYMASTER FP; WHITESITT CA; SHANNON HE; DELAPP N; WARD JS; CALLIGARO DO; SHIPLEY LA; BUELKESAM JL; BODICK NC; FARDE L; SHEARDOWN MJ; OLESEN PH; HANSEN KT; SUZDAK PD; SWEDBERG MDB; SAUERBERG P; MITCH CH
      XANOMELINE - A SELECTIVE MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE

      Drug development research
    77. NYBERG S; FARDE L
      THE RELEVANCE OF SEROTONERGIC MECHANISMS IN THE TREATMENT OF SCHIZOPHRENIA HAS NOT BEEN CONFIRMED

      JOURNAL OF PSYCHOPHARMACOLOGY
    78. FARDE L; MACK RJ; NYBERG S; HALLDIN C
      D-2 OCCUPANCY, EXTRAPYRAMIDAL SIDE-EFFECTS AND ANTIPSYCHOTIC DRUG-TREATMENT - A PILOT-STUDY WITH SERTINDOLE IN HEALTHY-SUBJECTS

      International clinical psychopharmacology
    79. FARDE L
      HOW CAN WE IMPROVE COMPLIANCE IN SCHIZOPHRENIA - PAPERS FROM A SATELLITE SYMPOSIUM TO THE XXTH-CONGRESS OF THE LEGIUM-INTERNATIONALE-NEURO-PSYCHOPHARMACOLOGICUM, MELBOURNE, AUSTRALIA, 24 JUNE 1996 - CONCLUSIONS

      International clinical psychopharmacology
    80. LUNDKVIST C; LOCH C; HALLDIN C; BOTTLAENDER M; OTTAVIANI M; COULON C; MATHIS C; FARDE L; MAZIERE B
      CHARACTERIZATION OF BR-76 LABELED 5-BROMO-6-NITROQUIPAZINE FOR PET STUDIES OF THE SEROTONIN TRANSPORTER

      The Journal of nuclear medicine
    81. HALLDIN C; FOGED C; SWAHN CG; GINOVART N; FARDE L
      [C-11] NNC-22-0215, A METABOLICALLY STABLE BENZAZEPINE DEVELOPED AS DOPAMINE D-1 RECEPTOR RADIOLIGAND FOR PET

      The Journal of nuclear medicine
    82. ITO H; NYBERG S; HALLDIN C; LUNDKVIST C; FARDE L
      5-HT2A RECEPTOR IMAGING IN THE HUMAN BRAIN USING [C-11] MDL-100,907 AND PET

      The Journal of nuclear medicine
    83. LOCH C; GUILLEM E; MARTINOT JL; HALLDIN C; SYROTA A; FARDE L; MAZIERE B
      NEUROLEPTIC INTERACTIONS ON THE IN-VIVO DOPAMINE D2 EXTRASTRIATAL BINDING OF BR-76 FLB-457 STUDIED BY PET IN HUMAN

      The Journal of nuclear medicine
    84. ITO H; HALLDIN C; LUNDKVIST C; SWAHN CG; PIKE V; FARDE L
      5-HT1A RECEPTOR IMAGING IN THE HUMAN BRAIN USING [C-11] WAY-100635 AND PET

      The Journal of nuclear medicine
    85. FARDE L; GUSTAVSSON JP; JONSSON E
      D2 DOPAMINE-RECEPTORS AND PERSONALITY-TRAITS

      Nature
    86. VOLKOW ND; ROSEN B; FARDE L
      IMAGING THE LIVING HUMAN BRAIN - MAGNETIC-RESONANCE-IMAGING AND POSITRON EMISSION TOMOGRAPHY

      Proceedings of the National Academy of Sciences of the United Statesof America
    87. HALL H; LUNDKVIST C; HALLDIN C; FARDE L; PIKE VW; MCCARRON JA; FLETCHER A; CLIFFE IA; BARF T; WIKSTROM H; SEDVALL G
      AUTORADIOGRAPHIC LOCALIZATION OF 5-HT1A RECEPTORS IN THE POSTMORTEM HUMAN BRAIN USING [H-3] WAY-100635 AND [C-11] WAY-100635

      Brain research
    88. GINOVART N; LUNDIN A; FARDE L; HALLDIN C; BACKMAN L; SWAHN CG; PAULI S; SEDVALL G
      PET STUDY OF THE PRESYNAPTIC AND POSTSYNAPTIC DOPAMINERGIC MARKERS FOR THE NEURODEGENERATIVE PROCESS IN HUNTINGTONS-DISEASE

      Brain
    89. BACKMAN L; ROBINSWAHLIN TB; LUNDIN A; GINOVART N; FARDE L
      COGNITIVE DEFICITS IN HUNTINGTONS-DISEASE ARE PREDICTED BY DOPAMINERGIC PET MARKERS AND BRAIN VOLUMES

      Brain
    90. NYBERG S; FARDE L; HALLDIN C
      DELAYED NORMALIZATION OF CENTRAL D-2 DOPAMINE-RECEPTOR AVAILABILITY AFTER DISCONTINUATION OF HALOPERIDOL DECANOATE - PRELIMINARY FINDINGS

      Archives of general psychiatry
    91. FARDE L; SUHARA T; NYBERG S; KARLSSON P; NAKASHIMA Y; HIETALA J; HALLDIN C
      A PET STUDY OF [C-11]FLB-457 BINDING TO EXTRASTRIATAL D-2-DOPAMINE RECEPTORS IN HEALTHY-SUBJECTS AND ANTIPSYCHOTIC DRUG-TREATED PATIENTS

      Psychopharmacology
    92. FARDE L; GINOVART N; ITO H; LUNDKVIST C; PIKE VW; MCCARRON JA; HALLDIN C
      PET-CHARACTERIZATION OF [CARBONYL-C-11]WAY-100635 BINDING TO 5-HT1A RECEPTORS IN THE PRIMATE BRAIN

      Psychopharmacology
    93. ANDREE B; HALLDIN C; VRIJMOEDDEVRIES M; FARDE L
      CENTRAL 5-HT2A-RECEPTOR AND D-2-DOPAMINE-RECEPTOR OCCUPANCY AFTER SUBLINGUAL ADMINISTRATION OF ORG-5222 IN HEALTHY-MEN

      Psychopharmacology
    94. FARDE L; SUHARA T; HALLDIN C; NYBACK H; NAKASHIMA Y; SWAHN CG; KARLSSON P; GINOVART N; BYMASTER FP; SHANNON HE; FOGED C; SUZDAK PD; SAUERBERG P
      PET STUDY OF THE M(1)-AGONISTS [C-11] XANOMELINE AND [C-11] BUTYLTHIO-TZTP IN MONKEY AND MAN

      Dementia
    95. LOCH C; HALLDIN C; BOTTLAENDER M; SWAHN CG; MORESCO RM; MAZIERE M; FARDE L; MAZIERE B
      PREPARATION OF [BR-76]FLB-457 AND [BR-76]FLB-463 FOR EXAMINATION OF STRIATAL AND EXTRASTRIATAL DOPAMINE D-2 RECEPTORS WITH PET

      Nuclear medicine and biology
    96. FOGED C; HALLDIN C; LOCH C; MAZIERE B; KARLSSON P; MAZIERE M; SWAHN CG; FARDE L
      C-11-LABELED AND BR-76-LABELED NNC-22-0010, SELECTIVE DOPAMINE D-1 RECEPTOR RADIOLIGANDS FOR PET

      Nuclear medicine and biology
    97. OSMAN S; LUNDKVIST C; PIKE VW; HALLDIN C; MCCARRON JA; SWAHN CG; GINOVART N; LUTHRA SK; BENCH CJ; GRASBY PM; WIKSTROM H; BARF T; CLIFFE IA; FLETCHER A; FARDE L
      CHARACTERIZATION OF THE RADIOACTIVE METABOLITES OF THE 5-HT1A RECEPTOR RADIOLIGAND, [O-METHYL-C-11]WAY-100635, IN MONKEY AND HUMAN PLASMA BY HPLC - COMPARISON OF THE BEHAVIOR OF AN IDENTIFIED RADIOACTIVE METABOLITE WITH PARENT RADIOLIGAND IN MONKEY USING PET

      Nuclear medicine and biology
    98. FOGED C; HALLDIN C; HILTUNEN J; BRAESTRUP C; THOMSEN C; HANSEN HC; SUHARA T; PAULI S; SWAHN CG; KARLSSON P; LARSSON S; FARDE L
      DEVELOPMENT OF I-123 LABELED NNC-13-8241 AS A RADIOLIGAND FOR SPECT VISUALIZATION OF BENZODIAZEPINE RECEPTOR-BINDING

      Nuclear medicine and biology
    99. NAGREN K; HALLDIN C; SWAHN CG; SUHARA T; FARDE L
      [C-11] METARAMINOL, A FALSE NEUROTRANSMITTER - PREPARATION, METABOLITE STUDIES AND POSITRON EMISSION TOMOGRAPHY EXAMINATION IN MONKEY

      Nuclear medicine and biology
    100. NYBERG S; FARDE L; HALLDIN C
      TEST-RETEST RELIABILITY OF CENTRAL [C-11] RACLOPRIDE BINDING AT HIGH D-2 RECEPTOR OCCUPANCY - A PET STUDY IN HALOPERIDOL-TREATED PATIENTS

      PSYCHIATRY RESEARCH-NEUROIMAGING


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 11:57:25